HomeInsightsStock Comparison

Novartis India Ltd vs Pfizer Ltd Stock Comparison

Novartis India Ltd vs Pfizer Ltd Stock Comparison

Last Updated on: Jun 02, 2025

Key Highlights

  • The Latest Trading Price of Novartis India Ltd is ₹ 1012 as of 02 Jun 16:01.
  • The P/E Ratio of Novartis India Ltd changed from 123.1 on March 2020 to 29.8 on March 2024 . This represents a CAGR of -24.70% over 5 yearsThe P/E Ratio of Pfizer Ltd changed from 36.2 on March 2020 to 34.8 on March 2024 . This represents a CAGR of -0.79% over 5 years.
  • The Market Cap of Novartis India Ltd changed from ₹ 1240 crore on March 2020 to ₹ 2539 crore on March 2024 . This represents a CAGR of 15.41% over 5 yearsThe Market Cap of Pfizer Ltd changed from ₹ 18411 crore on March 2020 to ₹ 19184 crore on March 2024 . This represents a CAGR of 0.83% over 5 years.
  • The revenue of Novartis India Ltd for the Mar '25 is ₹ 94.51 crore as compare to the Dec '24 revenue of ₹ 103.6 crore. This represent the decline of -8.77% The revenue of Pfizer Ltd for the Mar '25 is ₹ 809.3 crore as compare to the Dec '24 revenue of ₹ 580.75 crore. This represent the growth of 39.35%.
  • The ebitda of Novartis India Ltd for the Mar '25 is ₹ 34.54 crore as compare to the Dec '24 ebitda of ₹ 36.18 crore. This represent the decline of -4.53% The ebitda of Pfizer Ltd for the Mar '25 is ₹ 444.89 crore as compare to the Dec '24 ebitda of ₹ 188.75 crore. This represent the growth of 135.7%.
  • The net profit of Novartis India Ltd changed from ₹ 20.26 crore to ₹ 29.3 crore over 8 quarters. This represents a CAGR of 20.26% The net profit of Pfizer Ltd changed from ₹ 93.53 crore to ₹ 330.94 crore over 8 quarters. This represents a CAGR of 88.10% .
  • The Dividend Payout of Novartis India Ltd changed from 244.84 % on March 2020 to 72.43 % on March 2024 . This represents a CAGR of -21.62% over 5 yearsThe Dividend Payout of Pfizer Ltd changed from 296.54 % on March 2020 to 29.04 % on March 2024 . This represents a CAGR of -37.17% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About Pfizer Ltd

  • Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
  • The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
  • It has its own manufacturing facility at Goa and Thane.
  • It has the distinction of being the first pharmaceutical company in India to start clinical research.
  • The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

Novartis India Ltd News Hub

News

Novartis India schedules AGM

Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be ...

Read more

10 May 2025 09:38

News

Board of Novartis India recommends final dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on...

Read more

10 May 2025 09:38

News

Novartis India to announce Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 9 May 2025....

Read more

28 Mar 2025 09:32

News

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January ...

Read more

28 Dec 2024 09:37

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

28 Sep 2024 10:07

News

Novartis India to declare Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 202...

Read more

28 Jun 2024 17:50

Pfizer Ltd News Hub

News

Pfizer to hold AGM

Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on ...

Read more

21 May 2025 11:43

News

Board of Pfizer recommends final dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:47

News

Board of Pfizer recommends special dividend

75th year of Pfizer announced that the Board of Directors of the Company at its meeting he...

Read more

20 May 2025 12:46

News

Board of Pfizer recommends special dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:46

News

Pfizer gallops after good Q4 outcome

Pfizer reported an exceptional profit of Rs 172.81 crore in Q4 March 2025, primarily due t...

Read more

20 May 2025 12:57

News

Volumes jump at Pfizer Ltd counter

BASF India Ltd, NLC India Ltd, Zensar Technologies Ltd, Newgen Software Technologies Ltd a...

Read more

20 May 2025 14:30

SWOT Analysis Of Pfizer Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Pfizer Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Novartis India Ltd and Pfizer Ltd

Which company has a larger market capitalization, Novartis India Ltd or Pfizer Ltd?

Market cap of Novartis India Ltd is 2,571 Cr while Market cap of Pfizer Ltd is 25,683 Cr

What are the key factors driving the stock performance of Novartis India Ltd and Pfizer Ltd?

The stock performance of Novartis India Ltd and Pfizer Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and Pfizer Ltd?

As of June 2, 2025, the Novartis India Ltd stock price is INR ₹1041.65. On the other hand, Pfizer Ltd stock price is INR ₹5614.2.

How do dividend payouts of Novartis India Ltd and Pfizer Ltd compare?

To compare the dividend payouts of Novartis India Ltd and Pfizer Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions